This study states that how Rapid antigen detection (RAD) immunoassays have arisen as an important option in contrast to RT-PCR for analysis of SARS-CoV-2 contamination in patients giving clinically viable COVID-19 [1]. RAD tests are easy to do and return results inside a brief timeframe, in this manner being appropriate for point-of-care testing (POCT). Besides, two as of late assessed RAD examines (BD Veritor System and the Panbio™ COVID-19 Ag Rapid Test Device) might be utilized as an intermediary for SARS-CoV-2 refined from respiratory parcel examples, accordingly permitting sensibly precise expectation of infectiousness [2,3]; yet this presumption anticipates further approval in bigger companions. The chance of utilizing RAD tests to distinguish SARS-CoV-2-tainted asymptomatic contacts of COVID-19 patients is engaging, as it could successfully add to limit local area SARS-CoV-2 spread through early location of exceptionally irresistible people [1], yet little is thought about how RAD tests act in this populace bunch [[4], [5], [6]]. Here, we report on the exhibition of the Panbio™ COVID-19 Ag Rapid Test Device (Abbott Diagnostic GmbH, Jena, Germany) directed at POC in this setting.
An aggregate of 634 back to back asymptomatic people (female, n = 355; middle age, 37 years; range, 9–87 years) went to at the Clínico-Malvarrosa Health Department (Valencia, Spain) were selected between 16 October and 20 November 2020.
Reference link- https://www.sciencedirect.com/science/article/pii/S1198743X20307825
